Digoxin
Digoxin is a pharmaceutical drug with 154 clinical trials. Currently 9 active trials ongoing. Historical success rate of 97.8%.
Success Metrics
Based on 131 completed trials
Phase Distribution
Phase Distribution
128
Early Stage
9
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
95.6%
131 of 137 finished
4.4%
6 ended early
9
trials recruiting
154
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 Inhibition
Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants
A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)
Digoxin Medulloblastoma Study
Clinical Trials (154)
An Open-label DDI Study to Investigate the Effect of Rilzabrutinib on P-gp, BCRP, OATP1B1 and OATP1B3 Inhibition
Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants
A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)
Digoxin Medulloblastoma Study
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity
A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Drug-Drug Interaction Study of Atumelnant in Healthy Participants
Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)
A Study of LY4515100 in Healthy Participants
A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride
Digoxin After Acute Heart Failure (DIG-DICA)
Digoxin In NASH (CODIN)
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands
Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 154